ArticleJAMA network open2023

Four-Component Recombinant Protein-Based Vaccine Effectiveness Against Serogroup B Meningococcal Disease in Italy.

Lorenzo Lodi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.